More

    Serum Institute seeks emergency authorisation for Covid-19 vaccine in India

    Must Read

    Covid 19 cases reached 22814 in Vadodara after 68 new cases on Wednesday

    Total 62 discharged from hospital taking the total to 21550 The number of positive...

    Kangana Ranaut’s Twitter account restricted temporarily

    Actress Kangana Ranaut on Wednesday tweeted that her Twitter account has been restricted temporarily. This comes after...

    Samsung Galaxy Tab Active rugged tablet launched

    Samsung has launched Galaxy Tab Active a rugged tablet built to meet the rigors of today`s mobile...

    The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation (EUA) for the Oxford Covid-19 vaccine in the country, official sources said.

    A day earlier, the Indian arm of US pharmaceutical giant Pfizer became the first to seek a similar approval from India’s drug regulator for its Covid-19 vaccine in the country, after securing similar clearances in the UK and Bahrain.

    The phase-three clinical trial of the Oxford Covid-19 vaccine–Covishield, is being conducted by the Pune-based Serum Institute of India (SII), co-sponsored by the Indian Council of Medical Research (ICMR), in various parts of the country in addition to clinical studies being carried out by Oxford-AstraZeneca in the UK and Brazil.

    Based on phase two and three clinical trial results, the SII with the help of the ICMR will pursue early availability of the vaccine for India, the country’s apex health research body had said last month.

    According to the ICMR, the SII has already manufactured 40 million doses of the vaccine under the at-risk manufacturing and stockpiling license it obtained from the DCGI.

    Official sources, citing the SII application said, the firm has stated that data from four clinical studies, two in the UK and one each in Brazil and India, shows that Covishield is highly effective against symptomatic and most importantly against severe Covid-19 infections.

    The results are in line with other coronavirus vaccines and because of the huge disease burden, Covishield is predicted to alleviate substantial Covid-19 mortality and morbidity, the firm is learnt to have said.

    The SII has also submitted 12 batches of the vaccine to the Central Drugs Laboratory (CDL) in Kasauli for testing, a source said.

    “In line with our philosophy we assure you that for Covid-19 vaccines also, we are committed to making our country ‘aatmanirbhar’ (self-reliant) and fulfilling our prime minister’s clarion call of ‘vocal for local’ and ‘making in India’ for the world,” stated the application signed by Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs at Serum Institute of India (SII).

    In view of all these facts and unmet medical needs in the interest of the public at large to save millions of people in the country and across the globe, early availability of a vaccine against Covid-19 is a necessity, the application further stated.

    According to sources, this vaccine is logistically feasible for distribution in the country’s urban and rural regions as it can be stored at two to eight degrees Celsius, which is an ideal temperature for being kept in cold storages in the country.

    As a rapid regulatory response, the DCGI on August 2 had given nod to SII for conducting the combined phase two and three human clinical trials of the Oxford Covid-19 vaccine in the country.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Latest News

    Samsung Galaxy Tab Active rugged tablet launched

    Samsung has launched Galaxy Tab Active a rugged tablet built to meet the rigors of today`s mobile...

    Kangana Ranaut’s Twitter account restricted temporarily

    Actress Kangana Ranaut on Wednesday tweeted that her Twitter account has been restricted temporarily. This comes after she made controversial remarks about...

    Samsung Galaxy Tab Active rugged tablet launched

    Samsung has launched Galaxy Tab Active a rugged tablet built to meet the rigors of today`s mobile workforce in the US. As...

    Realme to launch 5G smartphone with dimensity 1200 SoC

    Realme on Wednesday announced that it will be one of the first brands to introduce a smartphone with MediaTek's new Dimensity 1200...

    Offence registered under GujCTOC against Bichoo gang in Vadodara

    12 arrested police form teams to arrest leader Aslam Bodiya An offense was registered under Gujarat Control of Terrorism...

    More Articles Like This

    - Advertisement -